Monday, October 1, 2012

Completion of Pharmaceutical Linkage Study



Five years after starting the project, I am pleased to say the group's empirical work on domestic, regional and global pharmaceutical law and regulations is complete.

A few well deserved thank you's:
  • To all the students who not only did great work consistently under pressure but also pushed me to grow as a person;
    • Special thanks to Monika Sawicka and Jamil Sawani, both now in successful private practice, for their excellent work on drug approvals and drug patents, respectively;
  • To my writing partners, nationally and internationally, for making the work better and relevant to a wider audience;
  • To the few but brave PIs and Collaborators who wrote grants with me. God bless for your patience and perseverance;
  • To the CIHR, AHFMR, Munk Centre for International Studies, University of Toronto, and the University of Alberta for funding my research studies first as a Masters (LLM) and Doctoral (SJD) student in law and later as an Associate Professor;
  • To all individual Key Decision-Makers in federal and provincial government and courts of justice for sticking their necks out to support grant-related research in their fields when they were not entirely comfortable doing so;
  • To my mentors in law, medicine and medical science for providing excellent role models of what it means to be a scholar and a man;
  • To other individuals in scholarship and administration who provided just as valuable examples of what paths not to walk in life;
  • To the book, law journal, and blog editors who supported our work by selecting, editing and then publishing it;
  • To many people who, on reading the work, went out of their way to contact me and enter into discussions of mutual interest;
  • To the 26,000+ individuals who viewed and downloaded papers on BePress and SSRN author sites between 2007-2012;
  • To the 24,000+ people who viewed content on this blog;
    •  Top ten nations in rank order are: United States, Canada, Indonesia, Germany, Russia, Ukraine, India, United Kingdom, France, and China; and
  • To my wonderful family, without whom none of the work would have been possible.